Similar Articles
Clinical Scales for Multiple Sclerosis
Kadriye ARMUTLU, Rana KARABUDAK
Issue: 1997, Volume 3 - Issue 3-4
0
87
HLA Tissue Antigens in Multiple Sclerosis
Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL
Issue: 1996, Volume 2 - Issue 3-4
0
73
Serum Vitamin B12 and Folate Levels in Multiple Sclerosis
H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER
Issue: 1996, Volume 2 - Issue 3-4
0
81
Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.
Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM
Issue: 1996, Volume 2 - Issue 1-2
0
72
THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS
Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA
Issue: 1995, Volume 1 - Issue 4
0
75
Multiple Sclerosis Cases with Atypical Signs
Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY
Issue: 1995, Volume 1 - Issue 2
0
66
Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population
Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy
DOI: 10.4274/tnd.2021.63444
Issue: 2021, Volume 27 - Supplement 1
0
126
Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis
Rana KARABUDAK
Issue: 2009, Volume 15 - Supplement 3
0
125
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
Issue: 2009, Volume 15 - Supplement 3
0
103
Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports
Murat TERZİ
Issue: 2009, Volume 15 - Supplement 3
0
123